Clinical Trials Directory

Trials / Completed

CompletedNCT06654102

A Study to Evaluate the Cutaneous Effects of Deep Ultraviolet A +/- High-Energy Visible Blue Light Exposure

A Controlled, Single Center Study to Evaluate the Cutaneous Effects of Deep Ultraviolet A (UVA) +/- High-Energy Visible (HEV) Blue Light Exposure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Johnson & Johnson Consumer Inc. (J&JCI) · Industry
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to assess the level of pigmentation following an acute exposure of skin to light regimens representative of portions of the natural sunlight spectrum and that contain Deep UVA wavelengths with or without HEV Blue Light, as compared to non-irradiated control skin.

Conditions

Interventions

TypeNameDescription
OTHERDeep UVA IrradiationA timed series of 6 UV doses will be administered to subsites 2 to 7 within Test Site 1 and 2 using an accurately calibrated solar simulator by varying the irradiation intensity for each subsite and keeping the duration of irradiation constant for all subsites. The duration of irradiation for each test site will be 30 minutes.
OTHERDeep UVA+HEV Blue Light IrradiationA timed series of 6 UV doses will be administered to subsites 2 to 7 within Test Site 3 and 4 using an accurately calibrated solar simulator by varying the irradiation intensity for each subsite and keeping the duration of irradiation constant for all subsites. The duration of irradiation for each test site will be 30 minutes.

Timeline

Start date
2024-10-23
Primary completion
2024-11-26
Completion
2024-11-26
First posted
2024-10-23
Last updated
2024-12-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06654102. Inclusion in this directory is not an endorsement.